Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Inflammatory Bowel Diseases 1Gastrointestinal Hemorrhage 1Colonic Polyps 1Colonic Neoplasms 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 328Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 257lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diatrizoate Meglumine × Gastrointestinal × Clear all
NCT05726097 2024-02-28

Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure

Region Skane

Phase 3 Completed
147 enrolled
Gastrointestinal

Colonic Neoplasms, Colonic Polyps, Gastrointestinal Hemorrhage, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡